Last reviewed · How we verify

NCT05405816

Determination of Change in Reflux Disease After Sleeve Gastrectomy by Intraluminal Impedance and pH-meter

Completed NA Last updated 13 February 2023
What this trial tests

NA trial testing laparoscopic sleeve gastrectomy in Gastroesophageal Reflux Disease in 20 participants. Completed in 1 September 2022.

Timeline
1 January 2022
Primary endpoint
1 August 2022
1 September 2022

Quick facts

Lead sponsorFatih Sultan Mehmet Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingdouble
Primary purposediagnostic
Enrollment20
Start date1 January 2022
Primary completion1 August 2022
Estimated completion1 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Fatih Sultan Mehmet Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Gastroesophageal Reflux Disease or Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

710 / 5.000 Çeviri sonuçları Laparoscopic sleeve gastrectomy (LSG) has become the most common bariatric procedure in obesity. The overall relationship between sleeve gastrectomy and gastroesophageal reflux disease is still unclear. Only acid reflux can be detected in the esophagus with a standard 24-hour pH-meter. A 24-hour pH-meter is normal in 30-50% of patients with nonerosive reflux. Impedance-pH meter, on the other hand, is a newly developed technique and determines all kinds of reflux (gas, liquid, acid and non-acid), the level of reflux and the clearance time of the esophagus. This prospective series aims to examine the relationship between LSG operation and esophago-gastric physiology using intraluminal impedance testing before and after LSG operation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Systematic mapping of registered interventional studies addressing the top 10 research priorities in Barrett's oesophagus and gastro-oesophageal reflux disease.
    Gamakaranage C, Ratcliffe E, Britton J, Butler T, et al · · 2025 · PMID 40527525 · DOI 10.1136/bmjgast-2025-001738

Verify or expand the search:

Other trials of laparoscopic sleeve gastrectomy

Trials testing the same drug.

Other recruiting trials for Gastroesophageal Reflux Disease

Currently open trials in the same condition.

Other Fatih Sultan Mehmet Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05405816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing